Article info

Download PDFPDF

Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis
Free
  1. Correspondence to:
    Dr Lachy McLean
    Clinical Immunology and Analgesia, Merck and Co, RY34B-278, PO Box 2000, Rahway, NJ 07065, USA; iain_mcleanmerck.com
View Full Text

Citation

Pokorny V, McQueen F, Yeoman S, et al
Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis

Publication history

  • Accepted July 6, 2004
  • First published August 26, 2004.
Online issue publication 
February 11, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.